Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

This study has been completed.
Bill and Melinda Gates Foundation
FHI 360
National Institute of Allergy and Infectious Diseases (NIAID)
Medical Research Council, South Africa
University of Cape Town
University of Limpopo
United States Agency for International Development (USAID)
Information provided by:
Population Council Identifier:
First received: September 13, 2005
Last updated: October 21, 2005
Last verified: September 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2002
  Estimated Primary Completion Date: No date given